NUIX LIMITED (NXL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NXL

NXL - NUIX LIMITED

FNArena Sector : Software & Services
Year End: June
GICS Industry Group : NONE
Debt/EBITDA: 0.08
Index: ASX300 | ALL-ORDS | ALL-TECH

Nuix is an Australian technology company providing investigative analytics and intelligence software for transforming large amounts of data into actionable intelligence. The company listed in December 2020.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.865

03 Mar
2026

0.030

OPEN

$1.83

1.63%

HIGH

$1.88

1,668,856

LOW

$1.79

TARGET
$3.75 101.1% upside
OTHER COMPANIES IN THE SAME SECTOR
360 . ALC . AMX . AR9 . ATA . AV1 . BMT . COS . DOC . GTK . KYP . QOR . RDY . SKO . UBN . VGL . XF1 . YOJ .
FNARENA'S MARKET CONSENSUS FORECASTS
NXL: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx - 2.8 6.6 xxx
DPS (cps) xxx 0.0 N/A xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 27.1 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx-2.8
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx221.5 M
Book Value Per Share xxxxxxxxxxxxxxx87.9
Net Operating Cash Flow xxxxxxxxxxxxxxx26.9 M
Net Profit Margin xxxxxxxxxxxxxxx-4.16 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-3.19 %
Return on Invested Capital xxxxxxxxxxxxxxx-3.14 %
Return on Assets xxxxxxxxxxxxxxx-2.14 %
Return on Equity xxxxxxxxxxxxxxx-3.19 %
Return on Total Capital xxxxxxxxxxxxxxx1.31 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx25.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx2 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx23 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx40 M
Price To Book Value xxxxxxxxxxxxxxx2.49

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx22.8 M
Capex % of Sales xxxxxxxxxxxxxxx10.31 %
Cost of Goods Sold xxxxxxxxxxxxxxx77 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx140 M
Research & Development xxxxxxxxxxxxxxx34 M
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

24/02/2026

1

Overweight

$3.75

101.07%

Nuix's 1H26 result was better than Morgan Stanley's expectations while FY26 guidance was reaffirmed, including total annual contract value of $240-260m excluding any M&A benefit from Linkurious.

The broker notes 1H revenue rose 15% to $121m and adj earnings (EBITDA) increased 43% to $19m, with churn improving to 5.9%, while net dollar retention slipped to 101 from 107 last reported.

Morgan Stanley flags Nuix Neo as the key value driver, with Neo ACV up 148% y/y to $46.8m, supported by customer migration to SaaS and new wins, and the Neo 2.1 release, including semantic search and user interface upgrades, due to commence in March 2026.

The broker lifts revenue assumptions by 3% across FY26-28, which flows through to higher EPS estimates, but it also raises its weighted average cost of capital to reflect higher uncertainty and potential AI disruption across software multiples.

Morgan Stanley sticks with its Overweight rating and trims its price target to $3.75 from $4.35. Industry view: Overweight.

FORECAST
Morgan Stanley forecasts a full year FY26 EPS of 6.60 cents.
Morgan Stanley forecasts a full year FY27 EPS of 10.10 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

3

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Moelis

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Shaw and Partners

06/02/2026

0

Cessation of coverage

Shaw and Partners ceased coverage of Nuix due to a reallocation of resources.

Jarden

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

NXL STOCK CHART